These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
801 related articles for article (PubMed ID: 22105822)
1. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. Zhou J; Yu L; Gao X; Hu J; Wang J; Dai Z; Wang JF; Zhang Z; Lu S; Huang X; Wang Z; Qiu S; Wang X; Yang G; Sun H; Tang Z; Wu Y; Zhu H; Fan J J Clin Oncol; 2011 Dec; 29(36):4781-8. PubMed ID: 22105822 [TBL] [Abstract][Full Text] [Related]
2. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma. Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012 [TBL] [Abstract][Full Text] [Related]
3. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study. Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272 [TBL] [Abstract][Full Text] [Related]
4. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710 [TBL] [Abstract][Full Text] [Related]
5. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989 [TBL] [Abstract][Full Text] [Related]
6. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma. Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019 [TBL] [Abstract][Full Text] [Related]
7. A plasma microRNA panel for early detection of colorectal cancer. Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911 [TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Xu J; Wu C; Che X; Wang L; Yu D; Zhang T; Huang L; Li H; Tan W; Wang C; Lin D Mol Carcinog; 2011 Feb; 50(2):136-42. PubMed ID: 21229610 [TBL] [Abstract][Full Text] [Related]
9. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Yu F; Lu Z; Chen B; Dong P; Zheng J Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970 [TBL] [Abstract][Full Text] [Related]
10. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus. Tan Y; Ge G; Pan T; Wen D; Chen L; Yu X; Zhou X; Gan J PLoS One; 2014; 9(9):e107986. PubMed ID: 25238238 [TBL] [Abstract][Full Text] [Related]
11. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma. Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637 [TBL] [Abstract][Full Text] [Related]
12. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer. Wang WS; Liu LX; Li GP; Chen Y; Li CY; Jin DY; Wang XL Cancer Prev Res (Phila); 2013 Apr; 6(4):331-8. PubMed ID: 23430754 [TBL] [Abstract][Full Text] [Related]
13. Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis B. Omar H; Lim CR; Chao S; Lee MM; Bong CW; Ooi EJ; Yu CG; Tan SS; Abu Hassan MR; Menon J; Muthukaruppan R; Singh M; Nik Abdullah NA; Ooi BP; Ding RP; Low EJ; Tan F; Novak D; Harris DF; Yang H; Merican I; Liew CC J Clin Gastroenterol; 2015 Feb; 49(2):150-7. PubMed ID: 25569223 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis. Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228 [TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus. Hung CH; Hu TH; Lu SN; Kuo FY; Chen CH; Wang JH; Huang CM; Lee CM; Lin CY; Yen YH; Chiu YC Int J Cancer; 2016 Feb; 138(3):714-20. PubMed ID: 26264553 [TBL] [Abstract][Full Text] [Related]
16. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996 [TBL] [Abstract][Full Text] [Related]
17. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients. Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740 [TBL] [Abstract][Full Text] [Related]
18. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. Tomimaru Y; Eguchi H; Nagano H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Tomokuni A; Takemasa I; Umeshita K; Kanto T; Doki Y; Mori M J Hepatol; 2012 Jan; 56(1):167-75. PubMed ID: 21749846 [TBL] [Abstract][Full Text] [Related]
19. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Li L; Guo Z; Wang J; Mao Y; Gao Q Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Wong QW; Lung RW; Law PT; Lai PB; Chan KY; To KF; Wong N Gastroenterology; 2008 Jul; 135(1):257-69. PubMed ID: 18555017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]